期刊文献+

复方醋酸甲地孕酮片有关物质测定方法的建立 被引量:2

Establishment of a determination method for the related substances in compound megestrol acetate tablets
原文传递
导出
摘要 目的:建立复方醋酸甲地孕酮片有关物质测定方法。方法:采用LC-MS-UV联用技术对复方醋酸甲地孕酮片中最大杂质(杂质B)和次大杂质(杂质A)进行结构确证,并采用HPLC法对其定量,对其他杂质按自身对照法计算。采用Agela Vensuil XBP C18(L)色谱柱(4.6 mm×250 mm,5μm),流动相:乙腈-水(50∶50),流速:1.0 mL·min-1,检测波长:243 nm(杂质A、杂质B),291 nm(其他杂质),柱温:30℃,进样量:20μL。结果:杂质A和杂质B的浓度分别在0.308~10.28μg·mL-1和1.137~113.7μg·mL-1范围内线性关系良好,相关系数(n=5)均为1.000,平均回收率分别为101.9%和99.6%(n=9),RSD为0.83%和1.1%(n=3),最低检出限分别为0.5 ng和1.1 ng。结论:所建立的方法简便、快速,可准确测定该制剂中杂质含量。 To establish a method for the determination of the related substances of compound megestrol acetate tablets. Methods : The structures of the maximum impurity ( impurity B ) and secondary maximum impurity (impurity A)were confirmed by LC - MS and the contents of the two impurities were quantified by HPLC. Other impurities were calculated by the main component self - contrasted method. An Agela Venusil XBP C18 (L) (4.6 mm × 250 mm, 5μm) was used with a mobile phase of acetonitrile - water (50: 50). The flow rate was 1.0 mL · min-1 ,the detection wavelengths were 243 nm for impurity A and impurity B,and 291 nm for other impurities. The column temperature was 30 ℃, and the volume of injection was 20 μL. Results: Good linear correlations of impurity A and impurity B were observed within the ranges of 0. 308 - 10. 28 μg · mL-land 1. 137 - 113.7 μg · mL-1 (r = 1. 000) ( n = 5 ) ; the average recovery rates were 101.9% and 99.6% ( n = 9 ) , respectively. The RSDs were 0. 83% and 1.1% (n = 3). The limits of detection were 0.5 ng and 1.1 ng, respectively. Conclusion:The method is simple,rapid, and accurate for determination of impurity content in preparation of compound megestrol acetate tablets.
作者 李洁 党楠
出处 《药物分析杂志》 CAS CSCD 北大核心 2013年第11期1964-1970,共7页 Chinese Journal of Pharmaceutical Analysis
关键词 复方醋酸甲地孕酮片 有关物质 杂质A 杂质B 高效液相色谱法 液相色谱-质谱联用 质量控制 compound megestrol acetate tablets related substances impurity A impurity B HPLC LC - MS qualitycontrol
  • 相关文献

参考文献10

  • 1ChP(中国药典)[S].2010.The first supplement(第一增补本):296.
  • 2王小亮,刘雪峰,席志芳,衷红梅.硝酸咪康唑原料及其制剂有关物质测定方法的建立[J].药物分析杂志,2012,32(11):2025-2030. 被引量:7
  • 3王勇,陈硕,卢端萍,蒋婷婷,范明.HPLC-ESI-MS和HPLC法分析测定灵芝醇提物中3种灵芝酸[J].药物分析杂志,2013,33(2):292-298. 被引量:7
  • 4BP[S].2012.VolⅢ:2798.
  • 5Translated by ZHOU Hai-jun(周海钧主译).Technical Requirement for Registration of Pharmaceuticals for Human Use(Section of Quality) [M].Beijing(北京):People's Medical Publishing House(人民卫生出版社),2001.343.
  • 6刘艳娥,车慧,靳守东,梁爱君.HPLC法测定氧化樟脑注射液的有关物质[J].药物分析杂志,2012,32(5):861-864. 被引量:5
  • 7Klaus Annen,Thomas Linz,Karl-Heinz Neff,et al.Process for preparing 17alpha-acetoxy-6-methylenepregn-4-ene-3,20-dione,medroxyprogesterone acetate and megestrol acetate[M].US:2009/0012321 A1,2009-01-08.
  • 8Chan CC,Lam H,Lee YC,et al.Method validation for HPLC analysis of related substances in pharmaceutical drug products[M].In:Analytical Method Validation and Instruments Performance Verification.Hoboken,NJ:John Wiley & Sons,2005.27.
  • 9ChP(中国药典)[S].2010.Vol Ⅱ(二部):947.
  • 10ChP(中国药典)[S].2010.Vol Ⅱ(二部):Appendix(附录)XIX F.

二级参考文献27

  • 1庄江兴,陈育琳,林恬聪.HPLC法测定复方硝酸咪康唑软膏中硝酸咪康唑的含量[J].海峡药学,2004,16(5):80-81. 被引量:8
  • 2潘富友,梁华定,胡美莲,陈晓萍.反相高效液相色谱法测定硝酸咪康唑及其相关物质的含量[J].分析科学学报,2004,20(6):667-668. 被引量:4
  • 3刘建华,尹继业,杨德柱.硝酸咪康唑软膏有关物质检查方法的建立[J].医药导报,2007,26(9):1081-1083. 被引量:3
  • 4国家药典委员会.临床用药须知.北京:人民卫生出版社,2005.75.
  • 5FUQiang(傅强).药物分析实验方法学.北京.人民卫生出版社,2008.54.
  • 6ChP(中国药典).2010.VolI(一部):174.
  • 7GAO J J, MIN B S,AHN E M,et al. New triterpene aldehydes,lucial- dehydes A-C ,from Ganoderma lucidum and their cytotoxicity against murine and human tumor ceils. J Chem Pharm Bull,2002,50:837.
  • 8Tang W, Liu JW. , Zhao WM, et al. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells, J Life Sci ,2006,80:205.
  • 9Cheng CR, Yue QX, Wu ZY, et al. Cytotoxic triterpenoids from Gano- derma lucidum. J Phytochemistry ,2010 , 71 : 1579.
  • 10Lu QY, Jin YS, Zhang QF, et al. Ganoderma lncidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. J Cancer Letters ,2004,216:9.

共引文献17

同被引文献17

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部